Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinoma

3 Jul 2015

Abstract excerpt

// Nicholas C. Wolff 1,2,3 , Andrea Pavía-Jiménez 1,2,3 , Vanina T. Tcheuyap 1,2,3 , Shane Alexander 1,2,3 , Mridula Vishwanath 4,6 , Alana Christie 1 , Xian-Jin Xie 1 , Noelle S. Williams 1,4 , Payal Kapur 1,5 , Bruce Posner 4 , Renée M. McKay 1,3 and James Brugarolas 1,2,3 1 Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26219258
DOI: 10.18632/oncotarget.4773

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinomaPMID 26219258Read ↗

Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS OverproductionSemantic proximity Read ↗

Renal cell carcinoma: new insights and challenges for a clinician scientist.Semantic proximity Read ↗

Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis inductionSemantic proximity Read ↗

Prohibitin is a prognostic marker of relapse and therapeutic target to block chemotherapy resistance in Wilms tumorSemantic proximity Read ↗

<i>VHL</i> Synthetic Lethality Signatures Uncovered by Genotype-specific CRISPR-Cas9 ScreensSemantic proximity Read ↗

A Molecule Targeting VHL-Deficient Renal Cell Carcinoma that Induces AutophagySemantic proximity Read ↗

Rescuing the Function of Missense-Mutated Tumor Suppressor <i>VHL</i> using Stabilizing Small MoleculesSemantic proximity Read ↗

Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor HomoharringtonineSemantic proximity Read ↗

Natural (and Unnatural) Small Molecules as Pharmacological Chaperones and Inhibitors in Cancer.Semantic proximity Read ↗

Drug Library Screening for the Identification of Ionophores That Correct the Mistrafficking Disorder Associated with Oxalosis Kidney Disease.Semantic proximity Read ↗

Development of a phenotypic high-content assay to identify pharmacoperone drugs for the treatment of primary hyperoxaluria type 1 by high-throughput screening.Semantic proximity Read ↗

Mechanisms of resistance to VHL loss-induced genetic and pharmacological vulnerabilitiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.